{"database": "openregs", "table": "dockets", "rows": [["FDA-2013-D-1319", "FDA", "Draft Guidance for Industry on Pulmonary Tuberculosis:  Developing Drugs for Treatment; Availability", "Nonrulemaking", "2026-05-11T13:31:41Z", "0b00006481459aa8"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2013-D-1319"], "units": {}, "query_ms": 4.872066085226834, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}